Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+9.63%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$16.1B
AUM Growth
+$1.17B
(+7.9%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
13.92%
Holding
646
New
153
Increased
115
Reduced
140
Closed
146
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$269M |
| 2 |
Broadcom
AVGO
|
$192M |
| 3 |
AstraZeneca
AZN
|
$150M |
| 4 |
Intuitive Surgical
ISRG
|
$150M |
| 5 |
TE Connectivity
TEL
|
$146M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$480M |
| 2 |
AerCap
AER
|
$204M |
| 3 |
Western Digital
WDC
|
$184M |
| 4 |
Akamai
AKAM
|
$127M |
| 5 |
Illumina
ILMN
|
$112M |
Sector Composition
| 1 | Technology | 22.16% |
| 2 | Consumer Discretionary | 14.37% |
| 3 | Industrials | 13.47% |
| 4 | Healthcare | 12.99% |
| 5 | Financials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWKS
326
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $4.5M | 0.03% |
1,780,614
-1,000,000
| -36% | -$2.53M |
|
|
LENZ
327
LENZ Therapeutics
LENZ
$1.2B
| $4.43M | 0.03% |
+199,602
| New | +$4.43M |
|
328
Coherent
COHR
$15.2B
| $4.38M | 0.03% |
72,214
-1,588,569
| -96% | -$96.3M |
|
|
GB
329
DELISTED
Global Blue Group Holding
GB
| $4.34M | 0.03% |
827,662
-593,363
| -42% | -$3.11M |
|
330
Larimar Therapeutics
LRMR
$337M
| $4.17M | 0.03% |
+550,027
| New | +$4.17M |
|
|
LBPH
331
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $4.06M | 0.03% |
+187,879
| New | +$4.06M |
|
332
Joby Aviation
JOBY
$11.5B
| $4.02M | 0.02% |
750,000
+100,000
| +15% | +$536K |
|
333
Howmet Aerospace
HWM
$71.8B
| $3.83M | 0.02% |
56,041
-854,739
| -94% | -$58.5M |
|
334
Acumen Pharmaceuticals
ABOS
$87.2M
| $3.81M | 0.02% |
939,603
+206,400
| +28% | +$836K |
|
335
Celestica
CLS
$27.9B
| $3.66M | 0.02% |
81,360
-1,679
| -2% | -$75.5K |
|
336
Sprinklr
CXM
$2.02B
| $3.65M | 0.02% |
297,521
-2,972,630
| -91% | -$36.5M |
|
337
SoFi Technologies
SOFI
$30.7B
| $3.65M | 0.02% |
+500,000
| New | +$3.65M |
|
338
4D Molecular Therapeutics
FDMT
$340M
| $3.62M | 0.02% |
+113,590
| New | +$3.62M |
|
339
Merck
MRK
$212B
| $3.57M | 0.02% |
+27,057
| New | +$3.57M |
|
|
BOLD
340
Boundless Bio
BOLD
$25.7M
| $3.56M | 0.02% |
+250,000
| New | +$3.56M |
|
341
89bio
ETNB
$1.32B
| $3.49M | 0.02% |
300,000
-283,187
| -49% | -$3.3M |
|
342
PSQ Holdings
PSQH
$73.9M
| $3.4M | 0.02% |
632,133
+27,124
| +4% | +$146K |
|
343
Precision BioSciences
DTIL
$59.8M
| $3.39M | 0.02% |
+250,000
| New | +$3.39M |
|
344
Latham Group
SWIM
$960M
| $3.22M | 0.02% |
812,502
-200,000
| -20% | -$792K |
|
345
EyePoint Pharmaceuticals
EYPT
$966M
| $3.06M | 0.02% |
147,837
-39,003
| -21% | -$806K |
|
346
Peloton Interactive
PTON
$3.27B
| $3M | 0.02% |
+700,100
| New | +$3M |
|
|
ATYR
347
aTyr Pharma
ATYR
$550M
| $2.94M | 0.02% |
1,505,555
-950,000
| -39% | -$1.85M |
|
348
Hexcel
HXL
$5.16B
| $2.92M | 0.02% |
40,071
-23,573
| -37% | -$1.72M |
|
349
Amylyx Pharmaceuticals
AMLX
$910M
| $2.86M | 0.02% |
+1,008,607
| New | +$2.86M |
|
|
RGLS
350
DELISTED
Regulus Therapeutics
RGLS
| $2.68M | 0.02% |
+937,500
| New | +$2.68M |
|